What's breaking now, across thousands of outlets.
(RTTNews) - Revolution Medicines (RVMD) on Thursday said the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for RASONQUE (daraxonrasib) to treat adults with metastatic pancreatic adenocarcinoma who have re
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
The state of Virginia is emerging as an early winner as President Donald Trump prods drugmakers to increase their manufacturing investments in the US, securing at least $12.6 billion through…
Experts are warning that the UK is unprepared for crises. A refrigerator cyber-attack scare in France is the latest reminder of the risks What’s worrying French supermarket bosses should be prompting…
Catholic leader met top Vatican aide, as doctors say recovery proceeding after lung surgery to remove cancerous growth.
The FDA has finalized a rule allowing manufacturers to use salt substitutes in dozens of standardized foods.
